<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-GIN-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Guinea: Targeted country assistance</narrative>
   <narrative xml:lang="FR">Guin&#xE9;e (la): Aide cibl&#xE9;e aux pays</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Guinea</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="GN" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="GN" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Conakry</narrative>
   </name>
   <administrative code="GN" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>9.53795 -13.67729</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">687055</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1910364</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">839671</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">816246</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="GINPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">12000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-DALBERG2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">173006</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">51799</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">11127</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">287957</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">151166</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">118776</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-DALBERG2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">387317</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">39491</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">33951</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">726503</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">604326</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-BARRY2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">186585</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="GINPEF-TCA-DALBERG2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">191852</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">51401</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">154639</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">255195</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GINPEF-TCA-BARRY2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">190794</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="GINPEF-TCA-DALBERG2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">625452</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000801">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-10"></transaction-date>
   <value currency="USD" value-date="2021-03-10">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001568">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-08"></transaction-date>
   <value currency="USD" value-date="2021-04-08">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002389">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-27"></transaction-date>
   <value currency="USD" value-date="2021-05-27">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002390">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-27"></transaction-date>
   <value currency="USD" value-date="2021-05-27">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004971">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-18"></transaction-date>
   <value currency="USD" value-date="2021-10-18">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004972">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-10"></transaction-date>
   <value currency="USD" value-date="2021-11-10">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004973">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-10"></transaction-date>
   <value currency="USD" value-date="2021-11-10">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004974">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-10"></transaction-date>
   <value currency="USD" value-date="2021-11-10">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007560">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">12439</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">37317</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BARRY</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000850">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">12000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">118776</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001000">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-90825</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001162">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">49237</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001302">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">47237</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-13980</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001168">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-2490</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-60516</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">13980</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001173">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">2490</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">60516</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000058">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-21"></transaction-date>
   <value currency="USD" value-date="2020-01-21">13980</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000056">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-21"></transaction-date>
   <value currency="USD" value-date="2020-01-21">15874</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000058">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-21"></transaction-date>
   <value currency="USD" value-date="2020-01-21">2490</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000057">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-21"></transaction-date>
   <value currency="USD" value-date="2020-01-21">60516</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000895">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-21"></transaction-date>
   <value currency="USD" value-date="2020-04-21">60516</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001506">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-30"></transaction-date>
   <value currency="USD" value-date="2020-06-30">14961</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001503">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-30"></transaction-date>
   <value currency="USD" value-date="2020-06-30">9065</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002864">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-13"></transaction-date>
   <value currency="USD" value-date="2020-07-13">10145</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002865">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-13"></transaction-date>
   <value currency="USD" value-date="2020-07-13">7628</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002485">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-18"></transaction-date>
   <value currency="USD" value-date="2020-08-18">60516</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004511">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">-70661</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004511">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">70661</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-90370</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">90370</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005376">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-15325</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005376">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">15325</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000224">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-21"></transaction-date>
   <value currency="USD" value-date="2021-01-21">80522</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">-17101</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">17101</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000711">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">32523</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001434">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">8249</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001639">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-13"></transaction-date>
   <value currency="USD" value-date="2021-04-13">84365</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004305">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-20"></transaction-date>
   <value currency="USD" value-date="2021-09-20">34607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003097">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-27"></transaction-date>
   <value currency="USD" value-date="2021-09-27">89621</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005077">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-06"></transaction-date>
   <value currency="USD" value-date="2021-12-06">360</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000999">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-4421</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000332">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-01"></transaction-date>
   <value currency="USD" value-date="2019-12-01">36474</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-19746</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">19746</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000078">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-14"></transaction-date>
   <value currency="USD" value-date="2021-01-14">19746</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">9845</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-664</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">15951</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-15401</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">15401</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">488</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">225</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">3638</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000851">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">287957</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">453587</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">272916</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003306">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-13"></transaction-date>
   <value currency="USD" value-date="2021-07-13">154639</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000852">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">151166</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">163539</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">440787</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003404">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-20"></transaction-date>
   <value currency="USD" value-date="2021-07-20">255195</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-guinea-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Guinea 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-guinea-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Guinea 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-guinea-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Guinea 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-guinea-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Guinea 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-guinea-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Guinea 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-guinea-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Guinea 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-guinea-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Guinea 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-guinea-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Guinea 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-GIN" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(a) Un circuit adequat de distribution est operationnel et les equipements de la phase 2 du CCEOP sont install&#xE9;s et fonctionnels
 (b) Le PEV dispose d&apos;un document de Normes et Standars et PON valides
 (c) Au moins 80% des activi&#xE9;s du plan d&apos;amelioration sont mises en oeuvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="(a) Appui &#xE0; l&apos;amelioration de la gestion efficace des vaccins  
 1 Staff IP- P3 cold chain and logistic
 Specify approaches to skill-transfer or gap-filling where applicable: Mise en place d&apos;un plan de travail pour le coaching des logisticiens du niveau central, notamment le nouveau Responsable Logistique - Formation et supervision formative au niveau regional, district et centre de sante 
 Participation aux forums/ateliers d&apos;echanges d&apos;experience">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">(a) un Inventaire des &#xE9;quipements de la chaine du froid du froid est en cours et le rapport sera disponible a la fin du mois de Juillet 
(b) Les structures devant abriter les &#xE9;quipements dans le cadre du CCEOP sont identifi&#xE9;s pour trois regions ( Kindia, Boke et Mamou) en m&#xEA;me temps que l?inventaire. Ces structures seront valid&#xE9;es par le minist&#xE8;re en vue de l?&#xE9;laboration du plan Op&#xE9;rationnel de D&#xE9;ploiement de la 2e phase du CCEOP.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="(a) Appui &#xE0; l&apos;amelioration de la gestion efficace des vaccins  
 1 Staff IP- P3 cold chain and logistic
 Specify approaches to skill-transfer or gap-filling where applicable: Mise en place d&apos;un plan de travail pour le coaching des logisticiens du niveau central, notamment le nouveau Responsable Logistique - Formation et supervision formative au niveau regional, district et centre de sante 
 Participation aux forums/ateliers d&apos;echanges d&apos;experience">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">(a) un Inventaire des &#xE9;quipements de la chaine du froid du froid est en cours et le rapport sera disponible a la fin du mois de Juillet 
(b) Les structures devant abriter les &#xE9;quipements dans le cadre du CCEOP sont identifi&#xE9;s pour trois regions ( Kindia, Boke et Mamou) en m&#xEA;me temps que l?inventaire. Ces structures seront valid&#xE9;es par le minist&#xE8;re en vue de l?&#xE9;laboration du plan Op&#xE9;rationnel de D&#xE9;ploiement de la 2e phase du CCEOP.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la conception et la mise en oeuvre plans de rattrapage inspir&#xE9;s de nouvelles Directives OMS  pour la planification et la mise en ?uvre de la vaccination de rattrapage) des enfants zero dose (DTC1) dans les Districts sanitaires prioritaires &#xE0; fort impact de la pand&#xE9;mie Covid19 (Recruter, former, deployer et suivre 5 Experts nationaux en appui &#xE0; 5 R&#xE9;gions sanitaires prioritaires)">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; en cours. Les TDR des 5 Experts nationaux en appui &#xE0; 5 R&#xE9;gions sanitaires prioritaires sont en cours de validation (OMS et PEV central) pour prendre en compte en plus des strat&#xE9;gies de r&#xE9;duction des enfants/communaut&#xE9; Z&#xE9;ro dose &#xE0; travers les micro plans &#xE9;quit&#xE9; dans l?immunisation du projet RSS2/PEV sur financement conjoint de Gavi, OMS et UNICEF, les sessions de micro planification de la campagne int&#xE9;gr&#xE9;e (CAR/MenA/rattrapage syst&#xE9;matique) et l&apos;introduction en 2022 du VAR2 et du PCV dans le PEV syst&#xE9;matique.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;valuation de la mise en ?uvre des micro plans &#xE9;quit&#xE9;s et rattrapage des enfants 0 doses p. ar un cabinet d&apos;&#xE9;tude">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; en cours. les TDR pour le recrutement d&apos;un cabinet ou Equipe d&apos;Experts sont &#xE9;galement en cours de finalisation. Cette activit&#xE9; doit &#xEA;tre r&#xE9;alis&#xE9;e apr&#xE8;s la mise en ?uvre des micro plans &#xE9;quit&#xE9; dans l?immunisation avec le financement conjoint de Gavi ; OMS et UNICEF, des campagnes AVI (activit&#xE9;s de vaccination intensifi&#xE9;e) et campagne int&#xE9;gr&#xE9;e (CAR/MenA/rattrapage syst&#xE9;matique) en 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;valuation de la mise en ?uvre des micro plans &#xE9;quit&#xE9;s et rattrapage des enfants 0 doses p. ar un cabinet d&apos;&#xE9;tude">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le financement de cette activit&#xE9; est attendue.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la conception et la mise en oeuvre plans de rattrapage inspir&#xE9;s de nouvelles Directives OMS  pour la planification et la mise en ?uvre de la vaccination de rattrapage) des enfants zero dose (DTC1) dans les Districts sanitaires prioritaires &#xE0; fort impact de la pand&#xE9;mie Covid19 (Recruter, former, deployer et suivre 5 Experts nationaux en appui &#xE0; 5 R&#xE9;gions sanitaires prioritaires)">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le financement de cette activit&#xE9; est attendue.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la conception et la mise en oeuvre plans de rattrapage inspir&#xE9;s de nouvelles Directives OMS pour la planification et la mise en ?uvre de la vaccination de rattrapage) des enfants zero dose (DTC1) dans les Districts sanitaires prioritaires &#xE0; fort impact de la pand&#xE9;mie Covid19 (Recruter, former, deployer et suivre 5 Experts nationaux en appui &#xE0; 5 R&#xE9;gions sanitaires prioritaires)">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Voir le statut de l?activit&#xE9;1. Il s?agit d?une duplication de celle-ci.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;valuation de la mise en ?uvre des micro plans &#xE9;quit&#xE9;s et rattrapage des enfants 0 doses p. ar un cabinet d&apos;&#xE9;tude">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Voir le statut de l?activit&#xE9;2. Il s?agit d?une duplication de celle-ci.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 50% des activit&#xE9;s du Plan d&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es sont r&#xE9;alis&#xE9;es. Le groupe technique SNIS est fonctionnel. Le pool de 8 Experts nationaux deploy&#xE9;s dans les DRS sont supervis&#xE9;s par l&apos;IP3 (Data quality 
improvement/TCA/2019)  sur les directives de la qualit&#xE9; des donn&#xE9;es y 
compris l&apos;op&#xE9;rationalisation du DHIS2 dans les regions sanitaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es (Data Qualit&#xE9; improvement) par un IP3 (au BSD/MoH) de juillet &#xE0; d&#xE9;cembre 2020 et 1 consultant National/NOB (au PEV central)">
      <location ref="GN"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; a &#xE9;t&#xE9; reprogramm&#xE9;e &#xE0; la faveur de la lutte contre la COVID-19</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es (Data Qualit&#xE9; improvement) par un IP3 (au BSD/MoH) de juillet &#xE0; d&#xE9;cembre 2020 et 1 consultant National/NOB (au PEV central)">
      <location ref="GN"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; a &#xE9;t&#xE9; reprogramm&#xE9;e &#xE0; la faveur de la lutte contre la COVID-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Termes de r&#xE9;f&#xE9;rence et chronogramme de mise en ?uvre de la GEV externe sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;amelioration de la gestion efficace des vaccins 
  1 Staff IP- P3 cold chain and logistic">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">(a)	La structure du pays est import&#xE9;e dans l?outil EVM 2.0. 
(b)	L?&#xE9;valuateur principal est identifi&#xE9; et form&#xE9;e sur la mise en ?uvre de la GEV externe
(c)	La liste des &#xE9;valuateurs pour enregistrement dans l?outil par le ministre de sante et la confirmation de la date de la mise en ?uvre de la Gev externe sont en discussion avec le ministre de la sante</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un document des Proc&#xE9;dures op&#xE9;ratoires normalis&#xE9;es de la cha&#xEE;ne d?approvisionnement est disponible et valide par le partenaire ; 
Le plan d?optimisation de la cha&#xEE;ne d?approvisionnement /int&#xE9;gration avec la PCG est op&#xE9;rationnel ; 
Le rapport de a GEV externe est diposnible assorti du plan d&apos;amelioration des faiblesses relevees</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;amelioration de la gestion efficace des vaccins 
  1 Staff IP- P3 cold chain and logistic">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Draft du document des Proc&#xE9;dures op&#xE9;ratoires normalis&#xE9;es de la cha&#xEE;ne d?approvisionnement disponible. L?atelier de validation est pr&#xE9;vu avant fin D&#xE9;cembre 2021
Le consultant pour l?&#xE9;laboration du plan d?optimisation de la cha&#xEE;ne d?approvisionnement /int&#xE9;gration avec la PCG est disponible. Sont plan de travail est repartie en 3 phases : 
Phase 1 :
?	Travail en pr&#xE9;sentiel &#xE0; Conakry pendant 15 jours : du 20 octobre au 5 novembre) : Familiarisation avec la documentation, la probl&#xE9;matique et les acteurs de l?int&#xE9;gration (selon l?agenda propos&#xE9;) 
?	Travail &#xE0; distance : Compilation des informations recueillies et des exp&#xE9;riences d?autres pays / propositions provisoires sur les r&#xF4;les et responsabilit&#xE9;s des diff&#xE9;rentes parties prenantes.
Phase 2 :
?	Travail en pr&#xE9;sentiel 2 &#xE0; Conakry (15 jours ? d&#xE9;but d&#xE9;cembre) : Discussions approfondies avec le PEV et la PCG sur les propositions provisoires / Visites de terrain &#xE0; l?int&#xE9;rieur / Identification des besoins en RH ;
?	Travail &#xE0; distance : Compilations des r&#xE9;sultats des discussions et &#xE9;laboration, sur cette base, des drafts du manuel de proc&#xE9;dures et du cahier de charge / proposition sur les RH n&#xE9;cessaires
Phase 3 :
?	Travail en pr&#xE9;sentiel &#xE0; Conakry (15 jours ? 2&#xE8;me quinzaine de Janvier 2022) : Pr&#xE9;sentation et discussion des drafts du manuel de proc&#xE9;dures et du cahier de charge ainsi que des propositions sur les RH / discussions sur les co&#xFB;ts de gestion
?	Travail &#xE0; distance : Compilations des r&#xE9;sultats des discussions, finalisation du manuel de proc&#xE9;dures et du cahier de charge et propositions finales concernant les RH et les co&#xFB;ts de gestion des vaccins par la PCG
En ce qui concerne la GEV externe, le processus est en cours. La formation et le d&#xE9;ploiement des enqu&#xEA;teurs sont pr&#xE9;vus avant fin D&#xE9;cembre 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La proposition pour l&apos;introduction du PVC13/Rotavirus dans le PEV de routine est pr&#xE9;par&#xE9; et valid&#xE9; au 30 sept 2020;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la pr&#xE9;paration de la proposition d?introduction des vaccins PVC13 et Rotavirus (plans nationaux et Budgets d&#xE9;taill&#xE9;s) et faciliter les sessions &#xE0; cet effet.">
      <location ref="GN"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; a connu un d&#xE9;lai additionnel en raison de changement de priorit&#xE9;s de vaccination dans le pays et du contexte de co-&#xE9;pid&#xE9;mie (Covid-19, Rougeole, cVDPV2, Fi&#xE8;vre jaune et Ebola). Les efforts des acteurs nationaux &#xE9;taient orient&#xE9;s sur le contr&#xF4;le de ces &#xE9;pid&#xE9;mies . Toutefois, il pr&#xE9;vu une TC virtuelle avec le Minist&#xE8;re de la sant&#xE9; &#xE0; travers le PEV central, OMS, UNICEF, CDC et Gavi ce 2 d&#xE9;cembre 21 pour convenir un agenda d?introduction du PCV dans le PEV syst&#xE9;matique. Il convient de souligner que les fonds d&#xE9;di&#xE9;s sont expir&#xE9;s. Une autre reprogrammation s?av&#xE8;re indispensable &#xE0; cet effet.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la pr&#xE9;paration de la proposition d?introduction des vaccins PVC13 et Rotavirus (plans nationaux et Budgets d&#xE9;taill&#xE9;s) et faciliter les sessions &#xE0; cet effet.">
      <location ref="GN"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le Minist&#xE8;re de la sant&#xE9; n&apos;a pas clairement d&#xE9;fini si l&apos;introduction du PVC13/Rotavirus dans le PEV de routine sera effective ou non. Cette activit&#xE9; sera entam&#xE9;e une fois que l&apos;avis favorable du MoH est re&#xE7;u.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la pr&#xE9;paration de la proposition d?introduction des vaccins PVC13 et Rotavirus (plans nationaux et Budgets d&#xE9;taill&#xE9;s) et faciliter les sessions &#xE0; cet effet.">
      <location ref="GN"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le Minist&#xE8;re de la sant&#xE9; n&apos;a pas clairement d&#xE9;fini si l&apos;introduction du PVC13/Rotavirus dans le PEV de routine sera effective ou non. Cette activit&#xE9; sera entam&#xE9;e une fois que l&apos;avis favorable du MoH est re&#xE7;u.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Dalberg Global Development Advisors : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Strategic indicators for monitoring/improving EPI performance have been identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">1A et 1B : les parties prenantes ont travaill&#xE9; sur l&apos;identification des indicateurs strat&#xE9;giques et op&#xE9;rationnels lors de l&apos;atelier op&#xE9;rationnel qui s&apos;est d&#xE9;roul&#xE9; &#xE0; Kindia le 2 et 3 juin 2021. Lors de cet atelier, une priorisation a &#xE9;t&#xE9; faite sur base d&apos;une liste de 41 indicateurs provenant du cadre de performance du PEV. Les participants de l&apos;atelier ont pu identifier, pour chaque niveau de la pyramide sanitaire, les indicateurs les plus pertinents.
En synth&#xE8;se, 16 indicateurs peuvent &#xEA;tre consid&#xE9;r&#xE9;s comme prioritaires dans la mesure o&#xF9; ils sont pertinents soit pour les acteurs cl&#xE9;s de l&apos;&#xE9;cosyst&#xE8;me, soit pour le Minist&#xE8;re. =&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Operational indicators are identified and selected in agreement with the EPI manager</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">1B : les parties prenantes ont travaill&#xE9; sur l&apos;identification des indicateurs strat&#xE9;giques et op&#xE9;rationnels lors de l&apos;atelier op&#xE9;rationnel qui s&apos;est d&#xE9;roul&#xE9; &#xE0; Kindia le 2 et 3 juin 2021. Lors de cet atelier, une priorisation a &#xE9;t&#xE9; faite sur base d&apos;une liste de 41 indicateurs provenant du cadre de performance du PEV. Les participants de l&apos;atelier ont pu identifier, pour chaque niveau de la pyramide sanitaire, les indicateurs les plus pertinents.
En synth&#xE8;se, 16 indicateurs peuvent &#xEA;tre consid&#xE9;r&#xE9;s comme prioritaires dans la mesure o&#xF9; ils sont pertinents soit pour les acteurs cl&#xE9;s de l&apos;&#xE9;cosyst&#xE8;me, soit pour le Minist&#xE8;re. =&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Strategic and operational indicators are validated by the steering committee</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">1C: Ces indicateurs seront valid&#xE9;s lors de la reunion du comit&#xE9; technique du SNIS dans le courant du mois de Juillet. Cette r&#xE9;union devait se tenir le 24 juin mais les membres du comit&#xE9; SNIS &#xE9;tant en mission sur le terrain jusqu&apos;&#xE0; la fin du mois de juin, la r&#xE9;union a donc d&#xFB; &#xEA;tre report&#xE9;e &#xE0; une date ult&#xE9;rieure . =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Les indicateurs ont &#xE9;t&#xE9; revus et valid&#xE9;s lors du CCIA Technique du mois d&apos;ao&#xFB;t dans le cadre de la revue des priorit&#xE9;s du PEV. Les d&#xE9;tails sont pr&#xE9;sent&#xE9;s dans le support de pr&#xE9;sentation et du compte rendu du CCIA technique.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; The governance framework of the dashboard from the subnational level to the central level is developed and validated by the steering committee</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">1D: L&apos;essentiel des informations n&#xE9;cessaires &#xE0; l&apos;&#xE9;tablissement du cadre de gouvernance cible ont &#xE9;t&#xE9; collect&#xE9;es. 
Outre les s&#xE9;ances de travail organis&#xE9;es au niveau central, l&apos;atelier op&#xE9;rationnel a permis de collecter des informations cl&#xE9;s sur les r&#xF4;les et responsabilit&#xE9; des uns et des autres. Il a aussi permis de faire une cartographie des instances de gouvernance existantes &#xE0; tous les niveaux de la pyramide sanitaire. Le cadre de gouvernance sera valid&#xE9; lors de la r&#xE9;union du comit&#xE9; technique du SNIS dans le courant du mois de juillet. Cette r&#xE9;union devait se tenir le 24 juin mais les membres du comit&#xE9; SNIS &#xE9;tant en mission sur le terrain jusqu&apos;&#xE0; la fin du mois de juin, la r&#xE9;union a donc d&#xFB; &#xEA;tre report&#xE9;e &#xE0; une date ult&#xE9;rieure =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le cadre de gouvernance a &#xE9;t&#xE9; partag&#xE9; avec les membres du CCIA pour revue. Il n&apos;y a pas eu d&apos;observation particuli&#xE8;re.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; The system for managing and monitoring the indicators in the dashboard is drawn up, validated by the steering committee and shared at all levels.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">1E: Sur la base des informations obtenues lors des diff&#xE9;rents &#xE9;changes avec les parties prenantes au niveau central mais &#xE9;galement lors de l&apos;atelier op&#xE9;rationnel, l&apos;&#xE9;quipe de Dalberg a d&#xE9;fini le dispositif de suivi des indicateurs, que ce soit au niveau du pilotage qu&apos;au niveau de l&apos;&#xE9;volution de l&apos;&#xE9;tendue des indicateurs. 
Le premier point est d&#xE9;velopp&#xE9; dans le dispositif de remont&#xE9;e des alertes (enclenchement d&apos;action sp&#xE9;cifique en fonction du niveau d&apos;un indicateur), et le second point est trait&#xE9; au niveau des r&#xF4;les et responsabilit&#xE9;s des diff&#xE9;rents acteurs, mais &#xE9;galement des diff&#xE9;rentes instances. Il sera valid&#xE9; pendant la r&#xE9;union du comit&#xE9; SNIS du 7 juillet =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le dispositif de suivi des indicateurs est d&#xE9;crit dans le cadre de gouvernance et de performance.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A plan for rolling out the dashboard at all levels is defined</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">1F: Sur base d&apos;observations faites par les diff&#xE9;rentes parties prenantes, un plan de d&#xE9;ploiement a &#xE9;t&#xE9; conceptualis&#xE9;. Ce plan contient les activit&#xE9;s qui seront r&#xE9;alis&#xE9;es lors du d&#xE9;ploiement ainsi que la strat&#xE9;gie adopt&#xE9;e en termes de d&#xE9;ploiement g&#xE9;ographique. =&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; Required / existing data sources are collected on a regular basis.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data collection:
- Assess the required data sources (during a workshop with the end users to assess their needs)
- Assess the existing data sources and identify missing data sources (develop data collection tools)
- Create data collection &amp; integration processes on a regular basis">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">2A: Sur une liste de 41 indicateurs provenant du Cadre de performance du PEV, 16 indicateurs ont &#xE9;t&#xE9; consid&#xE9;r&#xE9;s comme prioritaires. Parmi ces 16 indicateurs : 
- 11 indicateurs n&#xE9;cessitent le d&#xE9;veloppement d&apos;outils de collecte des donn&#xE9;es afin de rester dans la logique de source de donn&#xE9;es unique, promu par le Minist&#xE8;re de la Sant&#xE9;. Il y a notamment les indicateurs financiers, le suivi des stocks, et certains indicateurs programmatiques. 
- 5 indicateurs sont d&#xE9;j&#xE0; disponibles dans le DHIS2, dont 1 indicateur que l&apos;on peut obtenir par d&#xE9;duction &#xE0; travers un autre indicateur existant dans le DHIS2 (il s&apos;agit du % d&apos;enfant z&#xE9;ro dose via le vaccin du BCG). 
Pour ces indicateurs, les donn&#xE9;es sont d&#xE9;j&#xE0; collect&#xE9;es sur une base r&#xE9;guli&#xE8;re, &#xE0; des fr&#xE9;quence variables (mensuelles ou trimestrielles) =&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; Data collection tools for required non-existing data sources have been developed and demonstrated their capacity to collect required data sets</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data collection:
- Assess the required data sources (during a workshop with the end users to assess their needs)
- Assess the existing data sources and identify missing data sources (develop data collection tools)
- Create data collection &amp; integration processes on a regular basis">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">2B: Les informations n&apos;existant pas seront collect&#xE9;es &#xE0; travers des formulaires int&#xE9;gr&#xE9;s au DHIS2. Ces formulaires sont en cours de d&#xE9;veloppement. Les acc&#xE8;s pour la cr&#xE9;ation de ces formulaires ont d&#xE9;j&#xE0; &#xE9;t&#xE9; activ&#xE9;s. =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data collection: - Assess the required data sources (during a workshop with the end users to assess their needs) - Assess the existing data sources and identify missing data sources (develop data collection tools) - Create data collection &amp; integration processes on a regular basis">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Des formulaires ont &#xE9;t&#xE9; d&#xE9;velopp&#xE9;s dans le DHIS2 pour la collecte d&apos;informations sur le PAO ainsi que sur le suivi des d&#xE9;cisions &#xE9;manant des instances de coordination et de pilotage.
=&gt; Completed
Concernant le suivi des stocks, la possibilit&#xE9; de connecter Esigl (base de donn&#xE9;es pour les stocks) au DHIS2 est en cours de discussion avec le SNIS et Kimonix. Etant donn&#xE9; qu&apos;il s&apos;agit d&apos;une base de donn&#xE9;es contenant des donn&#xE9;es allant au-del&#xE0; des informations li&#xE9;es &#xE0; la vaccination et que le processus d&apos;int&#xE9;gration d&apos;Esigl au DHIS2 est pilot&#xE9; par le BSD, Dalberg n&apos;a pas d&apos;autres choix que de s&apos;aligner avec les d&#xE9;lais fix&#xE9;s par la partie nationale. =&gt; Reprogrammed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Version V0 or MVP (Minimum Viable Product) is a generic/skeleton version of the dashboard. The infrastructure and the main features are built and available for first users. The dashboard already displays some data results but not all of them.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Dashboard tool development:
- Develop the infrastructure
- Build the backend (data computation and processing)
- Design the frontend/dashboard
- Develop the frontend&apos;s features">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">3A: Dans un premier temps, la V0 du tableau de bord contiendra uniquement les indicateurs avec des informations existantes. Cependant, cette version ne sera disponible aux premiers utilisateurs (points focaux) que dans le courant du trimestre 3 2021. Ce retard est d&#xFB; aux raisons suivantes : 
- Organisation tardive des ateliers d&#xFB; au contexte sanitaire, notamment l&apos;indisponibilit&#xE9; des parties prenantes qui sont fr&#xE9;quemment mobilis&#xE9;es sur le terrain. En effet, l&apos;atelier strat&#xE9;gique a &#xE9;t&#xE9; organis&#xE9; le 14 avril et l&apos;atelier op&#xE9;rationnel les 2 et 3 juin.
- Souci d&apos;avoir des indicateurs identifi&#xE9;s et un outil pertinent pour les utilisateurs. En ce sens, la conduite de ces ateliers &#xE9;tait d&#xE9;terminante afin de d&#xE9;finir les indicateurs et les sp&#xE9;cificit&#xE9;s fonctionnelles de l&apos;outil. 
- Impossibilit&#xE9; pour les &#xE9;quipes techniques de Dalberg de se connecter au serveur du DHIS2 entre mai et juin. Cet &apos;incident&apos;, sur lequel les &#xE9;quipes de Dalberg n&apos;avaient aucune responsabilit&#xE9; et/ou capacite d&apos;action, a fortement perturb&#xE9; le bon d&#xE9;roulement du d&#xE9;veloppement technique de l&apos;outil =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Dashboard tool development: - Develop the infrastructure - Build the backend (data computation and processing) - Design the frontend/dashboard - Develop the frontend&apos;s features">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">La V0 du tableau de bord est disponible depuis fin octobre dans l&apos;instance de formation du DHIS2. L&apos;int&#xE9;gration dans l&apos;instance de production est en cours.
Cependant, les utilisateurs ont d&#xE9;j&#xE0; la possibilit&#xE9; d&apos;acc&#xE9;der au tableau de bord dans l&apos;instance de formation.
Une d&#xE9;monstration du tableau de bord a &#xE9;t&#xE9; faite lors du CCIA du 12 novembre 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; The mapping of governance and coordination bodies at the central and decentralized levels is completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">4A: Toutes les instances de gouvernance ont &#xE9;t&#xE9; identifi&#xE9;es et r&#xE9;pertori&#xE9;es, du niveau central jusqu&apos;au niveau d&#xE9;centralis&#xE9;. =&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; An analysis of each governance body is carried out and a road map for transformation is developed at central, regional and district levels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">4B: Sur base des TDRs re&#xE7;us et de diff&#xE9;rents &#xE9;changes, les comit&#xE9;s de gouvernance et de coordination ont &#xE9;t&#xE9; analys&#xE9;s afin d&apos;identifier deux &#xE9;l&#xE9;ments :
- Dans quelle mesure ces comit&#xE9;s de gouvernance et de coordination sont-ils pertinents pour le renforcement du cadre de gouvernance et l&apos;am&#xE9;lioration de la performance du PEV ?
- Que faudrait-il mettre en place afin qu&apos;ils soient plus efficients, pertinents ?
=&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Systematic data collection and support for the revitalization of the data validation committees is ensured through a support plan with communities and districts, in close collaboration with technical partners (particularly WHO)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve data collection and use at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">5A: Cette activit&#xE9; d&#xE9;pend de l&apos;identification des districts de la phase 1. Ces districts ont &#xE9;t&#xE9; valid&#xE9;s durant le mois de Mai, et les visites de terrain ne d&#xE9;marreront qu&apos;en Juillet compte tenu du contexte actuel (notamment la crise sanitaire mobilisant tr&#xE8;s fr&#xE9;quemment les parties prenantes) =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve data collection and use at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Dans le cadre des diff&#xE9;rentes activit&#xE9;s (ateliers, supervision sur le terrain, r&#xE9;union 1:1, etc.), Dalberg a identifi&#xE9; les axes d&apos;am&#xE9;lioration pour le renforcement du processus de collecte des donn&#xE9;es que Dalberg a synth&#xE9;tis&#xE9; dans un document de synth&#xE8;se.
Par ailleurs, dans le cadre des ateliers de formation au niveau des districts sanitaires, Dalberg a partag&#xE9; avec eux les bonnes pratiques en mati&#xE8;re d&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es au niveau des centres de sant&#xE9;, mais aussi pour les cadres des districts sanitaires.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; A support (Gap-filling) to the planning, management and implementation of financial and programmatic activities is provided in the first six months in the selected districts to accelerate delivery and to have a better understanding of the different processes</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve management practices and planning process at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">6A: Au niveau central, l&apos;assistance aux acteurs dans leur activit&#xE9;s de planification est un processus continu. En ce sens, l&apos;&#xE9;quipe de Dalberg assiste les &#xE9;quipes du SNIS dans l&apos;organisation de leur instance de coordination.
Des discussions fr&#xE9;quentes ont lieu avec les &#xE9;quipes du PEV sur le support n&#xE9;cessaire et ad&#xE9;quat des &#xE9;quipes de Dalberg dans les activit&#xE9;s quotidiennes du PEV.
Au niveau d&#xE9;centralis&#xE9;, les districts de la phase 1 n&apos;ont &#xE9;t&#xE9; valid&#xE9;s qu&apos;en Mai. Les premiers contacts avec les Districts ont eu lieu fin Mai. Les visites terrain ne d&#xE9;marreront qu&apos;en Juillet. =&gt; On track</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;  Dedicated training to selected end users (champions) + knowledge transfer</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">7A: Lors des diff&#xE9;rents &#xE9;v&#xE8;nements organis&#xE9;s dans le cadre du projet (Ateliers, s&#xE9;ance de travail, entretien ...), l&apos;&#xE9;quipe Dalberg a r&#xE9;alis&#xE9; des focus sur les concepts cl&#xE9;s d&apos;un dispositif de gouvernance, les facteurs cl&#xE9;s de succ&#xE8;s du projet ainsi que de la m&#xE9;thodologie pour la d&#xE9;finition des indicateurs. Ces &#xE9;changes permettent un transfert de connaissance continu entre les &#xE9;quipes Dalberg et les parties prenantes
Ce travail s&apos;intensifiera dans les semaines &#xE0; venir lors des visites de terrains (districts de la phase 1). =&gt; On track</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;  Maintenance and support</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">7B: Le support et la maintenance du tableau de bord &#xE0; proprement parl&#xE9; d&#xE9;butera lors de la mise &#xE0; disposition de la V0 . N&#xE9;anmoins, les &#xE9;quipes de Dalberg restent &#xE0; la disposition des parties prenantes pour toutes questions concernant les sp&#xE9;cificit&#xE9;s fonctionnelles et techniques du projet =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Support to the EPI in the preparation and presentation of the various programmatic and financial reports will be provided</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; &#xE0; la demande et aussi dans le cadre du CCIA</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; All required data sources are collected on a regular basis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data collection:
- Assess the required data sources (during a workshop with the end users to assess their needs)
- Assess the existing data sources and identify missing data sources (develop data collection tools)
- Create data collection &amp; integration processes on a regular basis">
      <location ref="GN"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Des outils de collecte de donn&#xE9;es suppl&#xE9;mentaires au niveau des districts et r&#xE9;gions ont &#xE9;t&#xE9; con&#xE7;us ou bien am&#xE9;lior&#xE9;s pendant ce semestre. Ces outils ont ensuite &#xE9;t&#xE9; int&#xE9;gr&#xE9;s dans la plateforme DHIS2. Les utilisateurs devraient commencer &#xE0; incorporer les premi&#xE8;res donn&#xE9;es dans les outils de collecte de donn&#xE9;es d&apos;ici la fin de l&apos;ann&#xE9;e 2021.
Concernant le suivi des stocks, la possibilit&#xE9; de connecter Esigl (base de donn&#xE9;es pour les stocks) au DHIS2 est en cours de discussion avec le SNIS et Kimonix. Etant donn&#xE9; qu&apos;il s&apos;agit d&apos;une base de donn&#xE9;es contenant des donn&#xE9;es allant au-del&#xE0; des informations li&#xE9;es &#xE0; la vaccination et que le processus d&apos;int&#xE9;gration d&apos;Esigl au DHIS2 est pilot&#xE9; par le BSD, Dalberg n&apos;a pas d&apos;autres choix que de s&apos;aligner avec les d&#xE9;lais fix&#xE9;s par la partie nationale.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Version 1 is the final version of the dashboard. The infrastructure and all the required features are built and available for all the users. The dashboard displays all the data results</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Dashboard tool development:
- Develop the infrastructure
- Build the backend (data computation and processing)
- Design the frontend/dashboard
- Develop the frontend&apos;s features">
      <location ref="GN"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Des outils de collecte de donn&#xE9;es suppl&#xE9;mentaires au niveau des districts et r&#xE9;gions ont &#xE9;t&#xE9; con&#xE7;us ou bien am&#xE9;lior&#xE9;s pendant ce semestre. Ces outils ont ensuite &#xE9;t&#xE9; int&#xE9;gr&#xE9;s dans la plateforme DHIS2. Les utilisateurs devraient commencer &#xE0; incorporer les premi&#xE8;res donn&#xE9;es dans les outils de collecte de donn&#xE9;es d&apos;ici la fin de l&apos;ann&#xE9;e 2021.
Concernant le suivi des stocks, la possibilit&#xE9; de connecter Esigl (base de donn&#xE9;es pour les stocks) au DHIS2 est en cours de discussion avec le SNIS et Kimonix. Etant donn&#xE9; qu&apos;il s&apos;agit d&apos;une base de donn&#xE9;es contenant des donn&#xE9;es allant au-del&#xE0; des informations li&#xE9;es &#xE0; la vaccination et que le processus d&apos;int&#xE9;gration d&apos;Esigl au DHIS2 est pilot&#xE9;+L8 par le BSD, Dalberg n&apos;a pas d&apos;autres choix que de s&apos;aligner avec les d&#xE9;lais fix&#xE9;s par la partie nationale.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Tools for quality control of administrative, programmatic and financial data are designed, implemented and rolled out through a collaborative approach, with the involvement of health staff and communities, with the opportunity.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve data collection and use at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;activit&#xE9; a &#xE9;t&#xE9; initi&#xE9;e, notamment via la cr&#xE9;ation de formulaire reprenant les &#xE9;l&#xE9;ments cl&#xE9;s du PAO.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; The mapping of the planning process is developed and analyzed. Strengths and weaknesses are identified, and recommendations are developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve management practices and planning process at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">La cartographie des processus de planning a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e. L&apos;analyse est en cours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; An accountability framework is established in collaboration with the partners and validated by the steering committee.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le cadre de gouvernance a &#xE9;t&#xE9; partag&#xE9; avec les membres du CCIA pour revue. Il n&apos;y a pas eu d&apos;observation particuli&#xE8;re a ce jour.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; An improvement plan of the planning process including all partners, the Ministry of Health, the EPI and the departments in charge of planning is developed and shared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve management practices and planning process at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le plan d&apos;action pour l&apos;am&#xE9;lioration du processus de planning sera propos&#xE9; une fois l&apos;analyse termin&#xE9;e.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Knowledge transfer</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Le support et la maintenance du tableau de bord &#xE0; proprement parl&#xE9; d&#xE9;butera lors de l&apos;utilisation de la V0 par les utilisateurs . N&#xE9;anmoins, les &#xE9;quipes de Dalberg restent &#xE0; la disposition des parties prenantes pour toutes questions concernant les sp&#xE9;cificit&#xE9;s fonctionnelles et techniques du projet.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The selected districts are trained on the governance and accountability framework under the leadership of the EPI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Les districts s&#xE9;lectionn&#xE9;s ont &#xE9;t&#xE9; form&#xE9;s durant le mois de novembre. Les d&#xE9;tails figurent dans le rapport d&apos;activit&#xE9; et de support de formation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; An evaluation framework and a timeline for reviewing EPI performances at the central level and in the selected districts are developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Les d&#xE9;tails figurent dans le document de synth&#xE8;se du cadre de gouvernance et de performance. Le calendrier d&apos;&#xE9;valuation reste &#xE0; d&#xE9;finir.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Maintenance and support</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Lors des diff&#xE9;rents &#xE9;v&#xE8;nements organis&#xE9;s dans le cadre du projet (Ateliers, s&#xE9;ance de travail, entretien, etc.), l&apos;&#xE9;quipe Dalberg a r&#xE9;alis&#xE9; des focus groups sur les concepts cl&#xE9;s d&apos;un dispositif de gouvernance, les facteurs cl&#xE9;s de succ&#xE8;s du projet ainsi que de la m&#xE9;thodologie pour la d&#xE9;finition des indicateurs. Ces &#xE9;changes ont permis un transfert de connaissance continu entre les &#xE9;quipes Dalberg et les parties prenantes.
Ce travail s&apos;est intensifi&#xE9; ces derni&#xE8;res semaines lors des visites de terrains (districts de la phase 1).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Maintenance and support</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Lors des diff&#xE9;rents &#xE9;v&#xE8;nements organis&#xE9;s dans le cadre du projet (Ateliers, s&#xE9;ance de travail, entretien, etc.), l&apos;&#xE9;quipe Dalberg a r&#xE9;alis&#xE9; des focus groups sur les concepts cl&#xE9;s d&apos;un dispositif de gouvernance, les facteurs cl&#xE9;s de succ&#xE8;s du projet ainsi que de la m&#xE9;thodologie pour la d&#xE9;finition des indicateurs. Ces &#xE9;changes ont permis un transfert de connaissance continu entre les &#xE9;quipes Dalberg et les parties prenantes.
Ce travail s&apos;est intensifi&#xE9; ces derni&#xE8;res semaines lors des visites de terrains (districts de la phase 1).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Coaching sessions on the use of the dashboard to monitor key indicators and make appropriate decisions are conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Oui. Cette activit&#xE9; a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e lors des ateliers de formation au niveau d&#xE9;centralis&#xE9;, mais &#xE9;galement lors du dernier CCIA technique.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Decision-making committees are revitalized or created as necessary</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Oui. Voir les comptes rendus des CCIA ainsi que les supports de pr&#xE9;sentation lors des diff&#xE9;rents comit&#xE9;s au niveau central.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Tools for the preparation and management of decision-making bodies are developed at all levels.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="GN"></location>
     </target>
     <actual value="Completed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Oui. Voir les comptes rendus des CCIA ainsi que les supports de pr&#xE9;sentation lors des diff&#xE9;rents comit&#xE9;s au niveau central.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">les termes de references et le consultant sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;operationalisation du plan strategique et du plan operationnel de communication en faveur du PEV y compris la plan de synchronisation avec les medias publiques et privees">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">L?&#xE9;laboration des TDR de ce recrutement est en cours. La situation &#xE9;pid&#xE9;miologique de la Guin&#xE9;e se caract&#xE9;rise par des faibles couvertures vaccinales avec une tendance &#xE0; la baisse au fil des ann&#xE9;es. Un consultant NOC en C4D en appui au PEV pourra aider la Coordination Nationale du PEV &#xE0; dynamiser l?&#xE9;quipe de la communication de la coordination d&#xE9;j&#xE0; en sous-effectif. Le staff NOC pourra &#xE9;galement apporter son expertise technique pour am&#xE9;liorer les approches programmatiques actuellement en cours en vue d?obtenir de r&#xE9;sultats plus durables.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les couvertures g&#xE9;ographiques et l?effectif des populations que touchent les radios &#xE0; travers leurs diff&#xE9;rentes prestations est d&#xE9;finie et partag&#xE9;e avec toutes les m&#xE9;dias. 
un contrat avec le consortium des medias privees et bubliques&#xA0;un plan de synergie et de synchronisation avec la radio rurale nationale sont disponibles 
 Un plan media assorti de l?effectif des populations &#xE0; couvrir er des zones de couvertures est disponible et mis en ?uvre 
le plan de communication du PEV est mise en oeuvre et suivi
le contrat avec Fondation orange et le patronat de la Guinee sont operationnels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;operationalisation du plan strategique et du plan operationnel de communication en faveur du PEV y compris la plan de synchronisation avec les medias publiques et privees">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Les termes de r&#xE9;f&#xE9;rence sont disponibles. Disponibilit&#xE9;. Le consultant sera d&#xE9;ploy&#xE9; avant fin Janvier 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La plateforme de la &#xAB; 2&#xE8;me ann&#xE9;e de vie &#xBB;  en Guin&#xE9;e  et la politqiue nationale du PEV sont elabores et valides</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le d&#xE9;veloppement de la plateforme de la &#xAB; 2&#xE8;me ann&#xE9;e de vie &#xBB;  en Guin&#xE9;e avec l?appui du CDC y compris l&apos;elaboration de la politique nationale du PEV">
      <location ref="GN"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Project dates have been updated to 01 June - 30 November 2021. The 2YL consultant has been hired and has been building partnerships with the EPI, CDC CO, WHO and UNICEF. CDC is providing preliminary technical guidance to build out a country-specific 2YL platform guidance document and training for district health staff. The EPI is satisfied with the consultant.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le d&#xE9;veloppement de la plateforme de la &#xAB; 2&#xE8;me ann&#xE9;e de vie &#xBB;  en Guin&#xE9;e avec l?appui du CDC y compris l&apos;elaboration de la politique nationale du PEV">
      <location ref="GN"></location>
     </target>
     <actual value="Major Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Project dates have been updated to 01 June - 30 November 2021. The 2YL consultant has been hired and has been building partnerships with the EPI, CDC CO, WHO and UNICEF. CDC is providing preliminary technical guidance to build out a country-specific 2YL platform guidance document and training for district health staff. The EPI is satisfied with the consultant.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La plateforme de la &#xAB; 2&#xE8;me ann&#xE9;e de vie &#xBB; en Guin&#xE9;e et la politqiue nationale du PEV sont elabores et valides</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le d&#xE9;veloppement de la plateforme de la &#xAB; 2&#xE8;me ann&#xE9;e de vie &#xBB; en Guin&#xE9;e avec l?appui du CDC y compris l&apos;elaboration de la politique nationale du PEV">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">The 2YL platform draft document is to be validated by a national commission of experts on 26 November, with a training on the platform for provincial focal points on 15-16 November. The project has recently benefitted from heavy engagement of the CDC Country Office after encountering numerous roadblocks. Maintaining regular communication and engagement among partners has been challenging, especially from Atlanta-Guinea/Guinea-Atlanta, leading to information voids concerning funds spent, activities completed and real progress towards deliverables. The project is now on track to reach its deliverables by the project?s end date barring any additional setbacks in the final weeks of the project period. In the case of such delays, we will be in communication with the Gavi focal points to inform them of the nature of delays and estimated time to completion of deliverables.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete trainings on data management and analysis processes; Complete supervision visits to at least 3 sites; Complete analysis &gt;90% of specimens collected in 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC/DBD proposes the following activities to strengthen meningitis surveillance and early/rapid detection of disease epidemics to guide outbreak responses and country prepareness: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens at the national lab and labs in regions at high risk for meningitis; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. However, other activities were delayed. The country is expected to complete supervisory visits and specimen testing by December 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC/DBD proposes the following activities to strengthen meningitis surveillance and early/rapid detection of disease epidemics to guide outbreak responses and country prepareness: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens at the national lab and labs in regions at high risk for meningitis; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="GN"></location>
     </target>
     <actual value="On Track">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. However, other activities were delayed. The country is expected to complete supervisory visits and specimen testing by December 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete training of the national and &gt;1 regional labs on detection of bacterial meningitis using the latest effective technology; Implement in-country programs to ensure lab proficiency; Complete analysis &gt;90% of specimens collected between Jan-Aug 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CDC/DBD proposes the following activities to strengthen meningitis surveillance and early/rapid detection of disease epidemics to guide outbreak responses and country prepareness: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens at the national lab and labs in regions at high risk for meningitis; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. Topics covered specimen accessioning, data reporting and analysis, scientific data summary and interactive sessions. However, other activities were delayed. The country is expected to complete supervisory visits and specimen testing by December 2021. UPDATED REPORT FOR PEF TF 21.1.1 (Unable to add since already submitted): Due to COVID-19, completion of trainings were delayed, and Guinea is expected to completed trainings this summer and by December 2021 at the latest.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Dalberg Global Development Advisors : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The ICC  is functionnig up to the Gavi standards for National Coordination Forums.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue the work to strengthen the Interagency Coordination Committee (ICC)">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue the work to strengthen the Interagency Coordination Committee (ICC)">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The ICC is functionnig up to the Gavi standards for National Coordination Forums.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue the work to strengthen the Interagency Coordination Committee (ICC)">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">There are significant improvements in team management and in staff performance thanks to clearly defined incentives for high performance (training, increased responsability, visibility within the MoH, bonuses, etc.)
A culture of peer to peer learning has been created in the EPI with sessions occuring at regular intervals and set up autonomously by the staff between them.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop an EPI human resources management in accordance with recognized standard  and initiate performance management">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop an EPI human resources management in accordance with recognized standard  and initiate performance management">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">There are significant improvements in team management and in staff performance thanks to clearly defined incentives for high performance (training, increased responsability, visibility within the MoH, bonuses, etc.) A culture of peer to peer learning has been created in the EPI with sessions occuring at regular intervals and set up autonomously by the staff between them.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop an EPI human resources management in accordance with recognized standard and initiate performance management">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Key staff (max of 5 &quot;Champions&quot;) from the EPI program are trained in leadership skills to sustain the gains brought by the presence of the Management Partner.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify champions amongst the extended immunisation teams to groom them for peer-leadership and ensure overall strengthening of the EPI">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify champions amongst the extended immunisation teams to groom them for peer-leadership and ensure overall strengthening of the EPI">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify champions amongst the extended immunisation teams to groom them for peer-leadership and ensure overall strengthening of the EPI">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The EPI  team is demonstrating sustained change in business as usual as demonstrated by improved coordination among the EPI team, increased productivity of EPI team translated in better program execution and coverage performances improved.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reinforce the leadership of the EPI management team and provide them with the appropriate management approaches, techniques and tools">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reinforce the leadership of the EPI management team and provide them with the appropriate management approaches, techniques and tools">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The EPI team is demonstrating sustained change in business as usual as demonstrated by improved coordination among the EPI team, increased productivity of EPI team translated in better program execution and coverage performances improved.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reinforce the leadership of the EPI management team and provide them with the appropriate management approaches, techniques and tools">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The EPI  team is demonstrating sustained change in business as usual as demonstrated by metrics agreed upon in the initial institutional assessment (including coverage, vaccine availability of vaccines at all levels, etc.)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen management capacity of the EPI (DPEV) in the area of program management and vaccine management">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen management capacity of the EPI (DPEV) in the area of program management and vaccine management">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The EPI team is demonstrating sustained change in business as usual as demonstrated by metrics agreed upon in the initial institutional assessment (including coverage, vaccine availability of vaccines at all levels, etc.)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen management capacity of the EPI (DPEV) in the area of program management and vaccine management">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The teams have developped an efficient way of collaborating both internally and externally. The EPI  team is also demonstrating sustained change in its modes or operation.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The teams have developped an efficient way of collaborating both internally and externally. The EPI team is also demonstrating sustained change in its modes or operation.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="GN"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Reprogrammed with country MoH</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Rescheduling process ongoing after delays have occured notably due to Covid 19 dysruptions</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed
2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="GN"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="GN"></location>
      <comment>
       <narrative xml:lang="EN">Rescheduling process ongoing after delays have occured notably due to Covid 19 dysruptions</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed 2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on VPD surveillance digital data package and know how to use it.
Costed scale up plan exist.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="GN"></location>
     </target>
     <actual>
      <location ref="GN"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
